Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Second response from Hawk on Feb. licenses

First, let me correct my comment as I wrote "omission of information" but intended "inclusion" of information.

Now, considering there has been no inclusion of information about on-going revenues or recurring payments, and considering the "material information" requirements I cited in my previous post and the revenue recognition clause that you cite (and that Ken from Hawk loves to cite, I might add lol), we should assume that there are no ongoing royalty payment structures or recurring revenue payment structures associated with any licenses to date.

Share
New Message
Please login to post a reply